ArticleCureus2024
Evidence of Significant Intratumoral Transcriptomic Heterogeneity in Non-functioning Pituitary Adenomas Based on Location and Texture.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Surgical resection remains a standard treatment of non-functioning pituitary adenomas (NFPA). These tumors have significant intratumoral variability of growth rates and texture hardness. This preliminary study aims to identify variations in gene expression of different locations and textures within the same tumor to better explain tumor pathophysiology. Methods NFPA tissue samples were collected from four non-consecutive surgical adult patients undergoing endoscopic endonasal resection and were sent for next-generation transcriptomics. Significantly differentially expressed (SDE) genes were analyzed and categorized using ontology within different locations of the tumor, tumor hardness, and across patients. Results Around 164 SDE genes were identified: 264 across tumor hardness and 68 across location marginality (core vs. edge). A total of 132 gene ontology annotations were matched to all SDE genes. Most of these annotations involved a combination of cell metabolism, cell-cell interactions, and cell division. Conclusions There was significant evidence of variations and uniqueness in intratumor genetic heterogeneity within different locations, tumor textures, and across patients. The tumor edge expressed higher cell-cell interaction genes such as cadherin-binding proteins. Soft portions of the tumor experienced an upregulation of anaerobic metabolism and cell division genes. The uniqueness of gene expressions can be tested for biological function, prospectively, with the potential targets for gene therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.